1. Adjuvant chemotherapy use and health care costs after introduction of genomic testing in breast cancer Author(s): Epstein, Andrew J., authorWong, Yu-Ning, authorMitra, Nandita, authorVachani, Anil, authorHin, Sakhena, authorYang, Lin, authorSmith-McLallen, Aaron, authorArmstrong, Katrina, authorGroeneveld, Peter W., author Publication: Philadelphia, PA : Leonard Davis Institute of Health Economics, 2016 Subject(s): Breast Neoplasms -- drug therapyBreast Neoplasms -- economicsBreast Neoplasms -- geneticsChemotherapy, Adjuvant -- economicsChemotherapy, Adjuvant -- utilizationGenetic Testing -- economicsGenetic Testing -- utilizationNeoplasm Recurrence, Local -- diagnosisNeoplasm Recurrence, Local -- economicsNeoplasm Recurrence, Local -- geneticsPharmacogenetics -- economicsAdultAgedAged, 80 and overBreast Neoplasms -- diagnosisDecision Support TechniquesMiddle AgedHumansUnited States